Pharmaceuticals in Southeast Asia: reality and future prospects

Abstract

The article is dedicated to the analysis of the pharmaceutical industry, one of the most actively developing sectors of the world economy, in the region of "new development" — Southeast Asia. It was found that at the present in the countries located in the region under consideration, there is a gradual shift away from the purely production stages of drug manufacturing in favour of an intersectoral pharmaceutical complex. There is a functional diversification of the pharmaceutical industry with deepening corporate specialization. However, a pronounced specialization in the production of a particular type of product is characteristic only for countries with high and medium levels of development of the pharmaceutical industry — Singapore, Malaysia and Indonesia. There is a gradual transformation of the territorial structure from monocentric — with a growth pole in the form of Singapore, to polycentric due to the growing contribution of Malaysia, Thailand and Indonesia. A distinctive feature of the pharmaceutical industry in Southeast Asia is the enclave type of development of its territorial structure at the country level. A significant part of production facilities and research laboratories is concentrated in one (capital), less often in two centres (the case of Indonesia — West and East Java and Vietnam with industrial cores in Hanoi and Ho Chi Minh City).